Boosting diagnosis accuracy of Alzheimer's disease using high dimensional recognition of longitudinal brain atrophy patterns

OBJECTIVE Boosting accuracy in automatically discriminating patients with Alzheimer's disease (AD) and normal controls (NC), based on multidimensional classification of longitudinal whole brain atrophy rates and their intermediate counterparts in analyzing magnetic resonance images (MRI). METHOD Longitudinal percentage of brain volume changes (PBVC) in two-year follow up and its intermediate counterparts in early 6-month and late 18-month are used as features in supervised and unsupervised classification procedures based on K-mean, fuzzy clustering method (FCM) and support vector machine (SVM). The most relevant features for classification are selected using discriminative analysis (DA) of features and their principal components (PC). Accuracy of the proposed method is evaluated in a group of 30 patients with AD (16 males, 14 females, age±standard-deviation (SD)=75±1.36 years) and 30 normal controls (15 males, 15 females, age±SD=77±0.88 years) using leave-one-out cross-validation. RESULTS Results indicate superiority of supervised machine learning techniques over unsupervised ones in diagnosing AD and withal, predominance of RBF kernel over lineal one. Accuracies of 83.3%, 83.3%, 90% and 91.7% are achieved in classification by K-mean, FCM, linear SVM and SVM with radial based function (RBF) respectively. CONCLUSION Evidence that SVM classification of longitudinal atrophy rates may results in high accuracy is given. Additionally, it is realized that use of intermediate atrophy rates and their principal components improves diagnostic accuracy.

[1]  Mark Rosen,et al.  A Multichannel Markov Random Field Framework for Tumor Segmentation With an Application to Classification of Gene Expression-Based Breast Cancer Recurrence Risk , 2013, IEEE Transactions on Medical Imaging.

[2]  Maximilian Reiser,et al.  Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment , 2007, NeuroImage.

[3]  Michael I. Miller,et al.  Evaluation of group-specific, whole-brain atlas generation using Volume-based Template Estimation (VTE): Application to normal and Alzheimer's populations , 2014, NeuroImage.

[4]  Xingfeng Li,et al.  Voxel-Based Morphometry and Its Application to Alzheimer’s Disease Study , 2014 .

[5]  F. Gage,et al.  Adult hippocampal neurogenesis and its role in Alzheimer's disease , 2011, Molecular Neurodegeneration.

[6]  Akram Bakkour,et al.  The effects of aging and Alzheimer's disease on cerebral cortical anatomy: Specificity and differential relationships with cognition , 2013, NeuroImage.

[7]  Nick C Fox,et al.  The clinical use of structural MRI in Alzheimer disease , 2010, Nature Reviews Neurology.

[8]  G. Alexander,et al.  Whole Brain Atrophy and Sample Size Estimate via Iterative Principal Component Analysis for Twelve-month Alzheimer's Disease Trials , 2013 .

[9]  Hiromu Nishitani,et al.  Neuroimaging study of myotonic dystrophy. II. MRI measurements of the brain , 1995, Brain and Development.

[10]  Stephen M. Smith,et al.  A global optimisation method for robust affine registration of brain images , 2001, Medical Image Anal..

[11]  Stephen M. Smith,et al.  Accurate, Robust, and Automated Longitudinal and Cross-Sectional Brain Change Analysis , 2002, NeuroImage.

[12]  D. Louis Collins,et al.  Automated segmentation of basal ganglia and deep brain structures in MRI of Parkinson’s disease , 2012, International Journal of Computer Assisted Radiology and Surgery.

[13]  Nick C Fox,et al.  Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images , 2001, The Lancet.

[14]  H. Hampel,et al.  Enrichment of MCI and early Alzheimer’s disease treatment trials using neurochemical & imaging candidate biomarkers , 2009, The journal of nutrition, health & aging.

[15]  M. Greicius,et al.  Decoding subject-driven cognitive states with whole-brain connectivity patterns. , 2012, Cerebral cortex.

[16]  C. Jack,et al.  Usefulness of MRI measures of entorhinal cortex versus hippocampus in AD , 2000, Neurology.

[17]  Stephen M. Smith,et al.  Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm , 2001, IEEE Transactions on Medical Imaging.

[18]  Mark Jenkinson,et al.  SIENA — Normalised accurate measurement of longitudinal brain change , 2000, NeuroImage.

[19]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[20]  Dana Horakova,et al.  Volumetric MRI Markers and Predictors of Disease Activity in Early Multiple Sclerosis: A Longitudinal Cohort Study , 2012, PloS one.

[21]  Frederik Barkhof,et al.  Whole-brain atrophy rate and CSF biomarker levels in MCI and AD: A longitudinal study , 2010, Neurobiology of Aging.

[22]  G. Frisoni,et al.  Hippocampal and entorhinal cortex atrophy in frontotemporal dementia and Alzheimer’s disease , 1999, Neurology.

[23]  Norbert Schuff,et al.  Optimizing power to track brain degeneration in Alzheimer's disease and mild cognitive impairment with tensor-based morphometry: An ADNI study of 515 subjects , 2009, NeuroImage.

[24]  N. Minshew,et al.  A preliminary longitudinal volumetric MRI study of amygdala and hippocampal volumes in autism , 2014, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[25]  Clifford R. Jack,et al.  Alzheimer's disease diagnosis in individual subjects using structural MR images: Validation studies , 2008, NeuroImage.

[26]  B. Xie,et al.  Voxel-based analysis of white matter during adolescence and young adulthood , 2010, Brain and Development.

[27]  Danielle J. Harvey,et al.  The Alzheimer's Disease Neuroimaging Initiative: Annual change in biomarkers and clinical outcomes , 2010, Alzheimer's & Dementia.

[28]  I. Jolliffe Principal Component Analysis , 2002 .

[29]  A. Simmons,et al.  Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease. , 2013, Journal of Alzheimer's disease : JAD.

[30]  J. Lucas,et al.  Tau-knockout mice show reduced GSK3-induced hippocampal degeneration and learning deficits , 2010, Neurobiology of Disease.

[31]  C. Mathers,et al.  Global prevalence of dementia: a Delphi consensus study , 2005, The Lancet.

[32]  N. Makris,et al.  MRI-based brain volumetrics: emergence of a developmental brain science , 1999, Brain and Development.

[33]  P. Visser,et al.  Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer’s disease? , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[34]  B. Fischl,et al.  Entorhinal verrucae correlate with surface geometry , 2012 .

[35]  M. Cusimano,et al.  Distinguishing Alzheimer's disease from normal pressure hydrocephalus: a search for MRI biomarkers. , 2013, Journal of Alzheimer's disease : JAD.

[36]  Michael I. Miller,et al.  Abnormalities of hippocampal surface structure in very mild dementia of the Alzheimer type , 2006, NeuroImage.

[37]  Nick C Fox,et al.  Automatic classification of MR scans in Alzheimer's disease. , 2008, Brain : a journal of neurology.

[38]  Nick C Fox,et al.  Volumetric MRI and cognitive measures in Alzheimer disease , 2008, Journal of Neurology.

[39]  et al.,et al.  Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline , 2008, NeuroImage.

[40]  F. Jessen,et al.  Multicentre variability of MRI-based medial temporal lobe volumetry in Alzheimer's disease , 2010, Psychiatry Research: Neuroimaging.

[41]  David N. Kennedy,et al.  Advanced application of magnetic resonance imaging in human brain science , 1995, Brain and Development.

[42]  T. Shiihara,et al.  Serial MRI changes in a patient with infantile Alexander disease and prolonged survival , 2011, Brain and Development.

[43]  S. S. Kumar,et al.  An automatic computer-aided diagnosis system for liver tumours on computed tomography images , 2013, Comput. Electr. Eng..

[44]  Mohammad Reza Daliri,et al.  Introduction to the special issue on Advances in Biomedical Signal and Image Processing, and Biometrics , 2015, Comput. Electr. Eng..

[45]  R. Buckner,et al.  The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects. , 2012, Cerebral cortex.

[46]  J. Alger 72 – Assessment of Neurobiological Diseases with Magnetic Resonance Spectroscopy , 2007 .

[47]  Christian Böhm,et al.  Automated detection of brain atrophy patterns based on MRI for the prediction of Alzheimer's disease , 2010, NeuroImage.

[48]  E. Westman,et al.  Cortical changes associated with depression and antidepressant use in Alzheimer and Lewy body dementia: an MRI surface-based morphometric study. , 2014, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[49]  David M. Holtzman,et al.  Biomarkers of Alzheimer's disease , 2009, Neurobiology of Disease.

[50]  Timothy Edward John Behrens,et al.  Automated Probabilistic Reconstruction of White-Matter Pathways in Health and Disease Using an Atlas of the Underlying Anatomy , 2011, Front. Neuroinform..